Cover Image
Market Research Report
Product code
1014943

North America Gene Synthesis Market- Industry Trends and Forecast to 2028

Published: | Data Bridge Market Research Private Limited | 150 Pages | Delivery time: 3-5 business days

Price

Back to Top
North America Gene Synthesis Market- Industry Trends and Forecast to 2028
Published: April 1, 2021
Data Bridge Market Research Private Limited
Content info: 150 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

North America gene synthesis market is projected to register a CAGR of 26.8% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

North America Gene Synthesis Market, By Product & Services (Software & Services, Consumables, Synthesizer), Gene Type (Standard Gene, Complex Gene, Express Gene, Others), Product Type (Custom Gene Synthesis, Gene Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, Others), Method (PCR Based Enzyme Synthesis, CHIP Based DNA Synthesis, Solid Phase Synthesis), End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, Other), Distribution Channel (Direct Tender, Online Distribution, Third Party Distributors), Country (U.S., Canada and Mexico) Industry Trends and Forecast To 2028

Some of the major factors contributing to the growth of the North America gene synthesis market are:

  • Growing interest of gene synthesis in field of molecular biology
  • Expanding field of synthetic biology

Market Players:

The key market players for North America gene synthesis market are listed below:

  • Bio Basic Inc.
  • Twist Bioscience
  • BioCat GmbH
  • Aldevron
  • Integrated DNA Technologies, Inc. (a subsidiary of Danaher)
  • Eurofins Scientific
  • bbi-lifesciences
  • Creative Biogene
  • Thermo Fisher Scientific Inc.
  • exonbio
  • Merck KGaA
  • Kaneka Eurogentec S.A.
  • LGC Limited
  • GenScript
  • GENEWIZ (a subsidiary of Brooks Automation, Inc.)
  • Codex DNA, Inc.
  • ATUM
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF NORTH AMERICA GENE SYNTHESIS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCT & SERVICES LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 NORTH AMERICA GENE SYNTHESIS MARKET: REGULATIONS

  • 4.1 OTHER STANDARD REGULATIONS IMPLEMENTED WORLDWIDE
  • 4.2 REGULATIONS RELATED TO BIODIVERSITY WHILE USING SYNTHETIC BIOLOGY

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 RISING PREVALENCE OF CHRONIC INFECTIOUS DISEASES
    • 5.1.2 RISING ADOPTION OF GENE THERAPY
    • 5.1.3 GROWING INTEREST OF GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY
    • 5.1.4 FAVORABLE GOVERNMENT INITIATIVES
    • 5.1.5 EXPANDING FIELD OF SYNTHETIC BIOLOGY
  • 5.2 RESTRAINTS
    • 5.2.1 ETHICAL ISSUES ASSOCIATED WITH GENETIC ENGINEERING
    • 5.2.2 THREAT IMPOSED TO ECOSYSTEM AND BIODIVERSITY
    • 5.2.3 LACK OF TRAINED PROFESSIONALS
    • 5.2.4 TECHNICAL LIMITATION ACROSS PRODUCTION PROCESS
  • 5.3 OPPORTUNITIES
    • 5.3.1 INCREASED FUNDING TOWARDS GENOMICS
    • 5.3.2 TECHNOLOGICAL ADVANCEMENTS
    • 5.3.3 INCREASING DEMAND OF PERSONALIZED MEDICINES
  • 5.4 CHALLENGES
    • 5.4.1 LONG APPROVAL PROCESS
    • 5.4.2 LACK OF WELL DEFINED PATENT SYSTEM

6 IMPACT OF COVID-19 ON THE NORTH AMERICA GENE SYNTHESIS MARKET

  • 6.1 IMPACT ON SUPPLY CHAIN
  • 6.2 IMPACT ON DEMAND
  • 6.3 STRATEGIC DECISION FOR MANUFACTURERS
  • 6.4 CONCLUSION

7 NORTH AMERICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES

  • 7.1 OVERVIEW
  • 7.2 SOFTWARE & SERVICES
  • 7.3 CONSUMBLES
    • 7.3.1 REAGENTS
    • 7.3.2 ASSAYS
    • 7.3.3 PROBES & DYES
    • 7.3.4 OTHERS
  • 7.4 SYNTHESIZER
    • 7.4.1 COLUMN-BASED SYNTHESIZERS
    • 7.4.2 MICROARRAY-BASED SYNTHESIZERS

8 NORTH AMERICA GENE SYNTHESIS MARKET, BY GENE TYPE

  • 8.1 OVERVIEW
  • 8.2 STANDARD GENE
  • 8.3 COMPLEX GENE
  • 8.4 EXPRESS GENE
  • 8.5 OTHERS

9 NORTH AMERICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE

  • 9.1 OVERVIEW
  • 9.2 CUSTOM GENE SYNTHESIS
  • 9.3 GENE LIBRARY SYNTHESIS

10 NORTH AMERICA GENE SYNTHESIS MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 SYNTHETIC BIOLOGY
  • 10.3 GENETIC ENGINEERING
  • 10.4 THERAPEUTIC ANTIBODIES
  • 10.5 VACCINE DESIGN
  • 10.6 OTHERS

11 NORTH AMERICA GENE SYNTHESIS MARKET, BY METHOD

  • 11.1 OVERVIEW
  • 11.2 PCR BASED ENZYME SYNTHESIS
  • 11.3 CHIP BASED DNA SYNTHESIS
  • 11.4 SOLID BASED SYNTHESIS

12 NORTH AMERICA GENE SYNTHESIS MARKET, BY END USER

  • 12.1 OVERVIEW
  • 12.2 ACADEMIC & RESEARCH INSTITUTE
  • 12.3 BIOTECH & PHARMACEUTICAL COMPANIES
  • 12.4 DIAGNOSTIC LABORATORIES
  • 12.5 OTHERS

13 NORTH AMERICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL

  • 13.1 OVERVIEW
  • 13.2 DIRECT TENDER
  • 13.3 ONLINE DISTRIBUTION
  • 13.4 THIRD PARTY DISTRIBUTORS

14 NORTH AMERICA GENE SYNTHESIS MARKET BY GEOGRAPHY

  • 14.1 NORTH AMERICA
    • 14.1.1 U.S.
    • 14.1.2 CANADA
    • 14.1.3 MEXICO

15 NORTH AMERICA GENE SYNTHESIS MARKET, COMPANY LANDSCAPE

  • 15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

16 SWOT ANALYSIS

17 COMPANY PROFILE

  • 17.1 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER)
    • 17.1.1 COMPANY SNAPSHOT
    • 17.1.2 REVENUE ANALYSIS
    • 17.1.3 COMPANY SHARE ANALYSIS
    • 17.1.4 PRODUCT PORTFOLIO
    • 17.1.5 RECENT DEVELOPMENTS
  • 17.2 THERMO FISHER SCIENTIFIC INC.
    • 17.2.1 COMPANY SNAPSHOT
    • 17.2.2 REVENUE ANALYSIS
    • 17.2.3 COMPANY SHARE ANALYSIS
    • 17.2.4 PRODUCT PORTFOLIO
    • 17.2.5 RECENT DEVELOPMENTS
  • 17.3 MERCK KGAA
    • 17.3.1 COMPANY SNAPSHOT
    • 17.3.2 REVENUE ANALYSIS
    • 17.3.3 COMPANY SHARE ANALYSIS
    • 17.3.4 PRODUCT PORTFOLIO
    • 17.3.5 RECENT DEVELOPMENTS
  • 17.4 EUROFINS SCIENTIFIC
    • 17.4.1 COMPANY SNAPSHOT
    • 17.4.2 REVENUE ANALYSIS
    • 17.4.3 COMPANY SHARE ANALYSIS
    • 17.4.4 SERVICE PORTFOLIO
    • 17.4.5 RECENT DEVELOPMENT
  • 17.5 BIO BASIC INC.
    • 17.5.1 COMPANY SNAPSHOT
    • 17.5.2 PRODUCT PORTFOLIO
    • 17.5.3 RECENT DEVELOPMENTS
  • 17.6 KANEKA EUROGENTEC S.A.
    • 17.6.1 COMPANY SNAPSHOT
    • 17.6.2 PRODUCT PORTFOLIO
    • 17.6.3 RECENT DEVELOPMENTS
  • 17.7 GENEWIZ (A SUBSIDIARY OF BROOKS AUTOMATION, INC.)
    • 17.7.1 COMPANY SNAPSHOT
    • 17.7.2 REVENUE ANALYSIS
    • 17.7.3 SERVICE PORTFOLIO
    • 17.7.4 RECENT DEVELOPMENTS
  • 17.8 LGC LIMITED
    • 17.8.1 COMPANY SNAPSHOT
    • 17.8.2 PRODUCT PORTFOLIO
    • 17.8.3 RECENT DEVELOPMENTS
  • 17.9 CREATIVE BIOGENE
    • 17.9.1 COMPANY SNAPSHOT
    • 17.9.2 SERVICE PORTFOLIO
    • 17.9.3 RECENT DEVELOPMENT
  • 17.10 GENSCRIPT
    • 17.10.1 COMPANY SNAPSHOT
    • 17.10.2 REVENUE ANALYSIS
    • 17.10.3 REAGENT SERVICE PORTFOLIO
    • 17.10.4 RECENT DEVELOPMENT
  • 17.11 CODEX DNA, INC.
    • 17.11.1 COMPANY SNAPSHOT
    • 17.11.2 PRODUCT PORTFOLIO
    • 17.11.3 RECENT DEVELOPMENTS
  • 17.12 BBI-LIFESCIENCES
    • 17.12.1 COMPANY SNAPSHOT
    • 17.12.2 REVENUE ANALYSIS
    • 17.12.3 PRODUCT PORTFOLIO
    • 17.12.4 RECENT DEVELOPMENT
  • 17.13 ALDEVRON
    • 17.13.1 COMPANY SNAPSHOT
    • 17.13.2 PRODUCT PORTFOLIO
    • 17.13.3 RECENT DEVELOPMENTS
  • 17.14 ATUM
    • 17.14.1 COMPANY SNAPSHOT
    • 17.14.2 SERVICE PORTFOLIO
    • 17.14.3 RECENT DEVELOPMENTS
  • 17.15 TWIST BIOSCIENCE
    • 17.15.1 COMPANY SNAPSHOT
    • 17.15.2 REVENUE ANALYSIS
    • 17.15.3 PRODUCT PORTFOLIO
    • 17.15.4 RECENT DEVELOPMENTS
  • 17.16 BIOCAT GMBH
    • 17.16.1 COMPANY SNAPSHOT
    • 17.16.2 PRODUCT PORTFOLIO
    • 17.16.3 RECENT DEVELOPMENT
  • 17.17 ATG:BIOSYNTHETICS GMBH
    • 17.17.1 COMPANY SNAPSHOT
    • 17.17.2 PRODUCT PORTFOLIO
    • 17.17.3 RECENT DEVELOPMENT
  • 17.18 EVONETIX
    • 17.18.1 COMPANY SNAPSHOT
    • 17.18.2 PLATFORM PORTFOLIO
    • 17.18.3 RECENT DEVELOPMENTS
  • 17.19 EXONBIO
    • 17.19.1 COMPANY SNAPSHOT
    • 17.19.2 SERVICE PORTFOLIO
    • 17.19.3 RECENT DEVELOPMENT
  • 17.20 TRENZYME GMBH
    • 17.20.1 COMPANY SNAPSHOT
    • 17.20.2 SERVICE PORTFOLIO
    • 17.20.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NORTH AMERICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 2 NORTH AMERICA SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 3 NORTH AMERICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 4 NORTH AMERICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 5 NORTH AMERICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 6 NORTH AMERICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 7 NORTH AMERICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 8 NORTH AMERICA STANDARD GENE IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 9 NORTH AMERICA COMPLEX GENE IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 10 NORTH AMERICA EXPRESS GENE IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 11 NORTH AMERICA OTHERS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 12 NORTH AMERICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 13 NORTH AMERICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 14 NORTH AMERICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 15 NORTH AMERICA GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 16 NORTH AMERICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 17 NORTH AMERICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 18 NORTH AMERICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 20 NORTH AMERICA OTHERS IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 21 NORTH AMERICA GENE SYNTHESIS MARKET, BY METHOD, 2017-2028 (USD MILLION)
  • TABLE 22 NORTH AMERICA PCR BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA CHIP BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 24 NORTH AMERICA SOLID PAHSE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 25 NORTH AMERICA GENE SYNTHESIS MARKET, BY END USER, 2017-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTE IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 27 NORTH AMERICA BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 28 NORTH AMERICA DIAGNOSTIC LABORATORY IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 29 NORTH AMERICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 30 NORTH AMERICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2017-2028 (USD MILLION)
  • TABLE 31 NORTH AMERICA DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 33 NORTH AMERICA THIRD PARTY DISTRIBUTOR IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 34 NORTH AMERICA GENE SYNTHESIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES 2019-2028 (USD MILLION)
  • TABLE 37 NORTH AMERICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 40 NORTH AMERICA GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 41 NORTH AMERICA GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 42 NORTH AMERICA GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 43 NORTH AMERICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 44 U.S. GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 45 U.S. CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES 2019-2028 (USD MILLION)
  • TABLE 46 U.S. SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 47 U.S. GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 48 U.S. GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 49 U.S. GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 50 U.S. GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 51 U.S. GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 52 U.S. GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 53 CANADA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 54 CANADA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES 2019-2028 (USD MILLION)
  • TABLE 55 CANADA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 56 CANADA GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 57 CANADA GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 58 CANADA GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 59 CANADA GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 60 CANADA GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 61 CANADA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 62 MEXICO GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 63 MEXICO CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES 2019-2028 (USD MILLION)
  • TABLE 64 MEXICO SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 65 MEXICO GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 66 MEXICO GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 67 MEXICO GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 68 MEXICO GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 69 MEXICO GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 70 MEXICO GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA GENE SYNTHESIS MARKET: SEGMENTATION
  • FIGURE 2 NORTH AMERICA GENE SYNTHESIS MARKET : DATA TRIANGULATION
  • FIGURE 3 NORTH AMERICA GENE SYNTHESIS MARKET: DROC ANALYSIS
  • FIGURE 4 NORTH AMERICA GENE SYNTHESIS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 NORTH AMERICA GENE SYNTHESIS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 NORTH AMERICA GENE SYNTHESIS MARKET: MULTIVARIATE MODELLING
  • FIGURE 7 NORTH AMERICA GENE SYNTHESIS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8 NORTH AMERICA GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 NORTH AMERICA GENE SYNTHESIS MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 10 NORTH AMERICA GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11 NORTH AMERICA GENE SYNTHESIS MARKET: SEGMENTATION
  • FIGURE 12 RISING ADOPTION OF GENE THERAPY IS EXPECTED TO DRIVE THE NORTH AMERICA GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 13 SOFTWARE & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA GENE SYNTHESIS MARKET IN 2021 & 2028
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA GENE SYNTHESIS MARKET
  • FIGURE 15 PEDIATRIC DEATHS CAUSE BY INFLUENZA (2017-2020) IN THE U.S.
  • FIGURE 16 NORTH AMERICA PREVALENCE OF HBV INFECTION (WORLDWIDE, 2018)
  • FIGURE 17 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, 2020
  • FIGURE 18 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, 2020-2028 (USD MILLION)
  • FIGURE 19 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, CAGR (2020-2028).
  • FIGURE 20 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
  • FIGURE 21 NORTH AMERICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2020
  • FIGURE 22 NORTH AMERICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2020-2028 (USD MILLION)
  • FIGURE 23 NORTH AMERICA GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2020-2028)
  • FIGURE 24 NORTH AMERICA GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE
  • FIGURE 25 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, 2020
  • FIGURE 26 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION)
  • FIGURE 27 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, CAGR (2020-2028)
  • FIGURE 28 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
  • FIGURE 29 NORTH AMERICA GENE SYNTHESIS MARKET: BY APPLICATION, 2020
  • FIGURE 30 NORTH AMERICA GENE SYNTHESIS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
  • FIGURE 31 NORTH AMERICA GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2020-2028)
  • FIGURE 32 NORTH AMERICA GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 33 NORTH AMERICA GENE SYNTHESIS MARKET: BY METHOD, 2020
  • FIGURE 34 NORTH AMERICA GENE SYNTHESIS MARKET: BY METHOD, 2020-2028 (USD MILLION)
  • FIGURE 35 NORTH AMERICA GENE SYNTHESIS MARKET: BY METHOD, CAGR (2020-2028)
  • FIGURE 36 NORTH AMERICA GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE
  • FIGURE 37 NORTH AMERICA GENE SYNTHESIS MARKET: BY END USER, 2020
  • FIGURE 38 NORTH AMERICA GENE SYNTHESIS MARKET: BY END USER , 2020-2028 (USD MILLION)
  • FIGURE 39 NORTH AMERICA GENE SYNTHESIS MARKET: BY END USER, CAGR (2020-2028)
  • FIGURE 40 NORTH AMERICA GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 41 NORTH AMERICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 42 NORTH AMERICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
  • FIGURE 43 NORTH AMERICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
  • FIGURE 44 NORTH AMERICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 45 NORTH AMERICA GENE SYNTHESIS MARKET: SNAPSHOT (2020)
  • FIGURE 46 NORTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2020)
  • FIGURE 47 NORTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 48 NORTH AMERICA GENE SYNTHESIS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 49 NORTH AMERICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE (2021-2028)
  • FIGURE 50 NORTH AMERICA GENE SYNTHESIS MARKET: COMPANY SHARE 2020 (%)